Granite Point Capital Management Portfolio holdings

Granite Point Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Granite Point Capital Management held 154 positions worth $1.12B, up 7.9% from $1.03B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Granite Point Capital Management deployed $59.9M of net new capital in Q2 2018, opening 47 new positions and adding to 20 existing holdings. Its largest new stake was Huaneng Power Intl, Inc.: 1,400,000 shares worth $928K.

By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, up from 4.5% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was GW Pharmaceuticals Plc American Depositary Shares, an estimated $3.15M trimmed.

• Granite Point Capital Management's largest Q2 2018 buy was Huaneng Power Intl, Inc.: 1,400,000 shares worth $928K.
• Granite Point Capital Management added most to Tellurian Inc. in Q2 2018, an estimated $7.01M increase.
• Granite Point Capital Management's biggest Q2 2018 reduction was GW Pharmaceuticals Plc American Depositary Shares, cutting an estimated $3.15M.
• Granite Point Capital Management fully exited Dine Brands in Q2 2018, selling an estimated $3.87M.
• Granite Point Capital Management's ten largest holdings make up 76% of its $1.12B portfolio in Q2 2018.
• Granite Point Capital Management opened 47 new positions and closed 36 in Q2 2018.
• Granite Point Capital Management's portfolio value rose 7.9% quarter-over-quarter to $1.12B.

Based on Granite Point Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.